These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 9485008)

  • 1. Short alternative splice transcripts of the mdm2 oncogene correlate to malignancy in human astrocytic neoplasms.
    Matsumoto R; Tada M; Nozaki M; Zhang CL; Sawamura Y; Abe H
    Cancer Res; 1998 Feb; 58(4):609-13. PubMed ID: 9485008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deregulation of the p14ARF/MDM2/p53 pathway is a prerequisite for human astrocytic gliomas with G1-S transition control gene abnormalities.
    Ichimura K; Bolin MB; Goike HM; Schmidt EE; Moshref A; Collins VP
    Cancer Res; 2000 Jan; 60(2):417-24. PubMed ID: 10667596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alternative and aberrant messenger RNA splicing of the mdm2 oncogene in invasive breast cancer.
    Lukas J; Gao DQ; Keshmeshian M; Wen WH; Tsao-Wei D; Rosenberg S; Press MF
    Cancer Res; 2001 Apr; 61(7):3212-9. PubMed ID: 11306511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of alternatively spliced mdm2 transcripts correlates with stabilized wild-type p53 protein in human glioblastoma cells.
    Kraus A; Neff F; Behn M; Schuermann M; Muenkel K; Schlegel J
    Int J Cancer; 1999 Mar; 80(6):930-4. PubMed ID: 10074928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amplification and overexpression of the MDM2 gene in a subset of human malignant gliomas without p53 mutations.
    Reifenberger G; Liu L; Ichimura K; Schmidt EE; Collins VP
    Cancer Res; 1993 Jun; 53(12):2736-9. PubMed ID: 8504413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathways leading to glioblastoma multiforme: a molecular analysis of genetic alterations in 65 astrocytic tumors.
    Lang FF; Miller DC; Koslow M; Newcomb EW
    J Neurosurg; 1994 Sep; 81(3):427-36. PubMed ID: 8057151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternatively spliced MDM2 transcripts in human breast cancer in relation to tumor necrosis and lymph node involvement.
    Hori M; Shimazaki J; Inagawa S; Itabashi M; Hori M
    Pathol Int; 2000 Oct; 50(10):786-92. PubMed ID: 11107050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alternative splicing of MDM2 mRNA in lung carcinomas and lung cell lines.
    Weng MW; Lai JC; Hsu CP; Yu KY; Chen CY; Lin TS; Lai WW; Lee H; Ko JL
    Environ Mol Mutagen; 2005 Jul; 46(1):1-11. PubMed ID: 15714438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel mdm2 splice variants identified in pediatric rhabdomyosarcoma tumors and cell lines.
    Bartel F; Taylor AC; Taubert H; Harris LC
    Oncol Res; 2001; 12(11-12):451-7. PubMed ID: 11939408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of alternatively and aberrantly spliced transcripts of the MDM2 mRNA is not tumor-specific.
    Bartel F; Pinkert D; Fiedler W; Kappler M; Würl P; Schmidt H; Taubert H
    Int J Oncol; 2004 Jan; 24(1):143-51. PubMed ID: 14654951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic organisation of the human MDM2 oncogene and relationship to its alternatively spliced mRNAs.
    Liang H; Atkins H; Abdel-Fattah R; Jones SN; Lunec J
    Gene; 2004 Sep; 338(2):217-23. PubMed ID: 15315825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alternatively spliced mdm2 transcripts with loss of p53 binding domain sequences: transforming ability and frequent detection in human cancer.
    Sigalas I; Calvert AH; Anderson JJ; Neal DE; Lunec J
    Nat Med; 1996 Aug; 2(8):912-7. PubMed ID: 8705862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amplification of the MDM2 gene, but not expression of splice variants of MDM2 MRNA, is associated with prognosis in soft tissue sarcoma.
    Bartel F; Meye A; Würl P; Kappler M; Bache M; Lautenschläger C; Grünbaum U; Schmidt H; Taubert H
    Int J Cancer; 2001 May; 95(3):168-75. PubMed ID: 11307150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor promotion by Mdm2 splice variants unable to bind p53.
    Fridman JS; Hernando E; Hemann MT; de Stanchina E; Cordon-Cardo C; Lowe SW
    Cancer Res; 2003 Sep; 63(18):5703-6. PubMed ID: 14522887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accumulation of wild type p53 protein in human astrocytomas.
    Rubio MP; von Deimling A; Yandell DW; Wiestler OD; Gusella JF; Louis DN
    Cancer Res; 1993 Aug; 53(15):3465-7. PubMed ID: 8339248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MIB-1 and p53 immunocytochemistry for differentiating pilocytic astrocytomas and astrocytomas from anaplastic astrocytomas and glioblastomas in children and young adults.
    Matsumoto T; Fujii T; Yabe M; Oka K; Hoshi T; Sato K
    Histopathology; 1998 Nov; 33(5):446-52. PubMed ID: 9839169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the molecular species generated by MDM2 gene amplification in liposarcomas.
    Tamborini E; Della Torre G; Lavarino C; Azzarelli A; Carpinelli P; Pierotti MA; Pilotti S
    Int J Cancer; 2001 Jun; 92(6):790-6. PubMed ID: 11351297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amplification and overexpression of MDM2 in primary (de novo) glioblastomas.
    Biernat W; Kleihues P; Yonekawa Y; Ohgaki H
    J Neuropathol Exp Neurol; 1997 Feb; 56(2):180-5. PubMed ID: 9034372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of MDM2 during mammary tumorigenesis.
    Pinkas J; Naber SP; Butel JS; Medina D; Jerry DJ
    Int J Cancer; 1999 Apr; 81(2):292-8. PubMed ID: 10188733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of alternatively-spliced MDM2 transcripts in giant cell tumours of bone.
    Evdokiou A; Atkins GJ; Bouralexis S; Hay S; Raggatt LJ; Cowled PA; Graves SE; Clayer M; Findlay DM
    Int J Oncol; 2001 Sep; 19(3):625-32. PubMed ID: 11494046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.